Globally,　lower　respiratory　infections　(LRTIs)　are　one　of　the　most　common　infectious　diseases　whichaffect　majority　of　the　population　and　as　a　result　of　inappropriate　antibiotics　practices　lead　to　antibiotic　resistance　(AR).　An　individual　randomized　control　trial　will　be　conducted　in　the　post-conflict　areas　of　Swat,　Pakistan,　through　a　random　sampling　method.　Patients　aged　＞　18　years　will　be　recruited　from　five　community　pharmacies　and　assigned　to　equally　sized　groups　to　receive　either　pharmacist-led　education　interventions　or　usual　care　with　no　intervention.　A　total　of　400　(control　=　200,　study　=　200)　patients　will　be　included,　with　prescriptions　comprised　of　antibiotics　for　LRTIs.　The　outcomes　measured　in　both　groups　will　be　a　combination　of　treatment　cure　rate　and　adherence,　which　will　be　assessed　using　the　Morisky　Medication　Adherence　Scale　and　pill　count.　The　trial　comprises　pharmacist-led　educational　interventions　to　improve　treatment　outcomes　for　patients　with　LRTIs.　This　study　might　establish　the　groundwork　for　pharmaceutical　care　of　LRTIs　patients　with　antibacterial　therapy　and　the　future　delivery　of　a　care　strategy　for　the　improvement　of　LRTIs　treatment　outcomes　in　post-conflict,　remote　areas　of　the　third　world　and　LMICs.